GlassScriptPhysician profile
Kerri Kroh
NPI 1063746782
$2,639.44
in general payments reported to CMS, 2019-2025
19 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $305 · 2022: $444 · 2023: $955 · 2024: $732 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $672.18 | 2021-2025 | |
| Novo Nordisk INC | $424.36 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $311.52 | 2021-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $284.74 | 2021-2024 | |
| Lilly USA, LLC | $278.18 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $103.90 | 2022-2024 | |
| Glaxosmithkline, LLC. | $88.09 | 2022-2024 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $69.81 | 2021-2023 | Xarelto |
| Exact Sciences Corporation | $67.64 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.97 | 2022-2024 | Synjardy, Jardiance, Stiolto Respimat |
| Medtronic, INC. | $60.11 | 2022-2023 | Minimed 770g |
| Merck Sharp & Dohme LLC | $41.13 | 2022-2024 | Gardasil, Gardasil 9, Capvaxive |
| Nestle Healthcare Nutrition INC. | $35.15 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.90 | 2023-2024 | Farxiga, Airsupra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $27.62 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $17.34 | 2022 | |
| Sanofi Pasteur INC. | $14.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerri Kroh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.